Better Glycemic Control and Weight Loss With the Novel Long-Acting Basal Insulin LY2605541 Compared With Insulin Glargine in Type 1 Diabetes: A randomized, crossover study

OBJECTIVE: To compare effects of LY2605541 versus insulin glargine on daily mean blood glucose as part of a basal-bolus regimen for type 1 diabetes. RESEARCH DESIGN AND METHODS: In this randomized, Phase 2, open-label, 2 × 2 crossover study, 137 patients received once-daily basal insulin (LY2605541...

Descripción completa

Detalles Bibliográficos
Autores principales: Rosenstock, Julio, Bergenstal, Richard M., Blevins, Thomas C., Morrow, Linda A., Prince, Melvin J., Qu, Yongming, Sinha, Vikram P., Howey, Daniel C., Jacober, Scott J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Diabetes Association 2013
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3579351/
https://www.ncbi.nlm.nih.gov/pubmed/23193209
http://dx.doi.org/10.2337/dc12-0067

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3579351/
https://www.ncbi.nlm.nih.gov/pubmed/23193209
http://dx.doi.org/10.2337/dc12-0067

Ejemplares similares